Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C15H24N2O |
| Molecular Weight | 248.3639 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 4 / 4 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
O=C1CCC[C@@H]2[C@H]3CCCN4CCC[C@H](CN12)[C@@H]34
InChI
InChIKey=ZSBXGIUJOOQZMP-BHPKHCPMSA-N
InChI=1S/C15H24N2O/c18-14-7-1-6-13-12-5-3-9-16-8-2-4-11(15(12)16)10-17(13)14/h11-13,15H,1-10H2/t11-,12-,13-,15+/m1/s1
| Molecular Formula | C15H24N2O |
| Molecular Weight | 248.3639 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 4 / 4 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
Sophoridine is a quinolizidine alkaloid isolated from traditional Chinese herbs, which exists in the stems and leafs of Leguminous plant Sophora alopecuroides L., Euchresta japonica Benth., and the roots of Sophora alopecuroides Ait. Sophoridine-induced synchronous oscillations in the hippocampus could elicit the generation and development of seizure. Accumulating evidence demonstrates remarkable pharmacological effects of Sophoridine, including anti-inflammatory, anti-virus and anti-cancer effects. Sophoridine is promising to be a novel, potent and selective antitumor drug candidate for pancreatic cancer. It was shown that sophoridine is able to suppress hepatocellular carcinoma in vitro and vivo. Sophoridine dose- and time-dependently blocks the RANKL-induced osteoclasts formation and the activation of ERK and c-Fos as well as the induction and nucleus translocation of NFATc1.
CNS Activity
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: RANKL-ERK-NFAT pathway Sources: https://www.ncbi.nlm.nih.gov/pubmed/29058425 |
|||
Target ID: WP254 Sources: https://www.ncbi.nlm.nih.gov/pubmed/28893319 |
|||
Target ID: PTEN/PI3K/AKT, Caspase-3/-9 and MMP-2/-9 signaling pathway Sources: https://www.ncbi.nlm.nih.gov/pubmed/28858730 |
Conditions
| Condition | Modality | Targets | Highest Phase | Product |
|---|---|---|---|---|
| Primary | Unknown Approved UseUnknown |
|||
| Primary | Unknown Approved UseUnknown |
|||
| Primary | Unknown Approved UseUnknown |
PubMed
| Title | Date | PubMed |
|---|---|---|
| Sophoridine from Sophora Flower Attenuates Ovariectomy Induced Osteoporosis through the RANKL-ERK-NFAT Pathway. | 2017-11-08 |
|
| Effect and Mechanism of Sophoridine to suppress Hepatocellular carcinoma in vitro and vivo. | 2017-11 |
|
| Sophoridine induces apoptosis and S phase arrest via ROS-dependent JNK and ERK activation in human pancreatic cancer cells. | 2017-09-11 |
|
| [Analysis and evaluation of alkaloids and flavonoids in flower of Sophora flavescens from Shanxi province]. | 2016-12 |
|
| [Comparison of alkaloids in roots of cultivated and wild Sophora flavsecens]. | 2016-11 |
|
| Sophoridine-loaded PLGA microspheres for lung targeting: preparation, in vitro, and in vivo evaluation. | 2016-11 |
|
| Dispersive Liquid-Liquid Microextraction Combined with High-Performance Liquid Chromatography for the Simultaneous Analysis of Matrine Alkaloids in Traditional Chinese Medicine. | 2016-10-17 |
|
| [Evaluation analysis of alkaloids in seed of Sophora flavescens from Shanxi province and exploration of its utilization value]. | 2016-09 |
Patents
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/29058425
Mice: 15 mg/kg body weight. The daily administration continued for 28 days.
Route of Administration:
Intraperitoneal
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/28893319
Eleven human cancer cell lines and 8 normal cell lines were exposed to various concentrations of Sophoridine (0–500 uM/L) for 48 h. Cell viability was determined by the CCK-8 assay. Sophoridine exhibited remarkable inhibition effects to the growth of human pancreatic, gastric, liver, colon, gallbladder, and prostate carcinoma
cells with IC50 values of about 20 uM/L to 200 uM/L.
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 22:41:56 GMT 2025
by
admin
on
Mon Mar 31 22:41:56 GMT 2025
|
| Record UNII |
W5S1M800J7
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
6882-68-4
Created by
admin on Mon Mar 31 22:41:56 GMT 2025 , Edited by admin on Mon Mar 31 22:41:56 GMT 2025
|
PRIMARY | |||
|
W5S1M800J7
Created by
admin on Mon Mar 31 22:41:56 GMT 2025 , Edited by admin on Mon Mar 31 22:41:56 GMT 2025
|
PRIMARY | |||
|
DTXSID60218927
Created by
admin on Mon Mar 31 22:41:56 GMT 2025 , Edited by admin on Mon Mar 31 22:41:56 GMT 2025
|
PRIMARY | |||
|
165549
Created by
admin on Mon Mar 31 22:41:56 GMT 2025 , Edited by admin on Mon Mar 31 22:41:56 GMT 2025
|
PRIMARY |